Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian and Primary Peritoneal Carcinoma

NCT00868192 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT00868192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00868192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian and Primary Peritoneal Carcinoma
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2008
Completion date
December 31, 2012
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian carcinoma, primary peritoneal carcinoma